Recognition Scheme >
NABL Medical Entry Level Testing (MELT)
Overview
NABL has launched a voluntary scheme namely “NABL Medical Entry Level Testing M(EL)T Labs Program” for sensitizing the medical testing laboratories performing basic testing to quality practices and access to quality health care for the majority of citizens especially those residing in villages, small towns.
This scheme is an independent quality assurance scheme, which is not covered under APAC & ILAC MRA
The existing scheme has been revised and now this scheme is based on satisfactory proficiency testing (PT) performance and valid for only ONE cycle of three years.
Laboratory application will be reviewed by NABL and decision on recognition will be taken based on performance in proficiency testing (PT). During the recognition period (within three years), on-site assessment (surveillance) will be conducted.
NABL will only recommend those tests in the scope of the laboratory which are available in the scope of the NABL accredited PT provider. Further, regarding the calibration certificate of equipment, it is recommended to calibrate the equipment from the calibrating laboratory for which it is accredited. The authenticity regarding the scope of calibration laboratory and accredited PT provider to be verified from NABL website.
This scheme is NOT applicable for:
- Laboratory in Medical College
- Medical Laboratory operating under a corporate group legal entity
- Laboratory in Hospital with 50 or more beds.”
Eligibility
- The applicant laboratory shall have satisfactorily participated in Proficiency Testing (PT) program conducted by accredited PT provider as per ISO/IEC 17043 before submission of application. (Refer NABL155 clause 2, condition b)
- Test parameters covered in last six months in PT programs shall be considered for recognition. Six months shall be calculated from date of application submission.
- PT result / report received date shall be considered for PT participation date
- Scope once recognized cannot be changed during recognition period. There is no provision for extension in scope in this scheme.
- Laboratory shall be legally identifiable
- Inhouse/ Open to others/ partially Open to others
- Laboratories of Educational Institutes
- Research and Development laboratory
Process
- Laboratory shall apply through web-portal only (http://nablmelt.qci.org.in).
- Laboratory location and its equipment shall be geo-tagged with the help of mobile app.
- Laboratory application shall be reviewed along with PT results.
- Decision on recognition shall be taken on the basis of satisfactory PT performance in last six months and communicated to the laboratory.
- Recognition certificate along with scope shall be visible to the laboratory after payment.
Scope of Scheme
1. HIV-1 antibodies
2. Clinical Biochemistry
| Sodium | Chloride | Potassium | Magnesium | Glucose | Amylase | Lipase | Calcium |
|---|---|---|---|---|---|---|---|
| D. Bilirubin | Glycated Hb (HbA1C) | Inorganic Phosphorus | Lactic Acid Dehydrogenase (LDH) | ||||
| Creatine Phosphokinase (CPK/CK) | Lipid Profile Cholesterol, Triglyceride | High Density Lipoprotein Cholesterol (HDL) | Gamma Glutamyl Transferase (GGT) | ||||
| Low Density Lipoprotein Cholesterol (LDL) | Renal Function Tests (Urea/Blood Urea Nitrogen, Creatinine, Uric acid) | Liver Function Tests (Total Bilirubin, Alanine Aminotransferase (ALT/SGPT), Aspartate Aminotransferase (AST/SGOT), Alkaline Phosphatase (ALP), Albumin, Total Protein) | |||||
3. Haematology
Haemogram/ CBC (Haemoglobin, Total Leucocyte Count (TLC), Differential Leucocyte Count (DLC – Lymphocyte, Monocyte, Basophils, Eosinophils, Neutrophils), Platelet count, Red Blood Cell Count (RBC) Count, Packed Cell Volume (PCV)/ Hematocrit (HCT), Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), Mean Corpuscular Haemoglobin Concentration (MCHC)4. Clinical Pathology (Urine Routine Examination)
| Protein | Glucose | pH | Leukocytes | Specific Gravity |
| Ketones | Bilirubin | Nitrite | Blood (Haemoglobin) | Urobilinogen |
5. Infectious Serology/Immunology (Rapid tests)
| Rheumatoid (RA)Factor | C-Reactive Protein (CRP) | Anti HCV/ HCV Ab | Typhoid (IgG / IgM) | WIDAL for Typhoid | Antistreptolysin O (ASO) |
|---|---|---|---|---|---|
| Hepatitis B Surface Antigen (HBsAg) | HIV Antigen + HIV Ab | Syphilis Serology (Rapid Plasma Reagin), VDRL, Treponema pallidum hemagglutination assay (TPHA) | |||
Fee Structure
| Components ▼ | Fee/Charges |
|---|---|
| Recognition Fee (for three year, payable before issue of certificate) | ₹ 15000 /- |
| Surveillance Charge (to be paid after the assessment via portal) | On actual basis |
| For details on other applicable fees, kindly refer NABL 100A. |
Note 2: Payment option for Recognition fee will be visible after issue of certificate and payment can be made through the gateway available in the portal.
Relevant Documents
| Document No. | Document Title | View Document |
|---|---|---|
| NABL 100A | General Information Brochure | View / Download |
| NABL 100B | Accreditation Process & Procedure | View / Download |
| NABL 128 | Criteria and Procedure for NABL Medical (Entry Level) Testing Labs {NABL M(EL)T Labs} Recognition Program | View / Download |
| NABL 155 | Application Form and Checklist for NABL Medical (Entry Level) Testing labs {NABL M(EL)T Labs} Recognition Program | View / Download |
Support
- nablmelt@nabl.qcin.org
- 011 4003 2452, 011 4003 2432, 011 4003 2457, 011 4003 2548, 011 4003 2555